Research
6 min read
Tirzepatide: the dual-pathway peptide
How engaging two metabolic pathways at once set tirzepatide apart, and what researchers study it for.
Read article
Tirzepatide
Tirzepatide 30mg
For in vitro research only
A synthetic 39-amino-acid dual-pathway metabolic research peptide supplied as a 30 mg lyophilized vial for research into incretin signaling, glucose-dependent insulin secretion, and energy-balance regulation.
Third-party testedView certificate
$171.56
Quantity
1
- Free shipping from $300
- Same-day shipping — order before 1 PM
- Secure payment
Promotion
Free 3 ml bacteriostatic water with every order.
Everything you need to start is included.
New
Advanced lab tests
HPLC tests
Endotoxin assay
TYMC test
TAMC test
Heavy metals screening
Technical specification
- Molecular formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Molar mass
- 4813.527 g/mol
- Purity
- ≥99%
- Synonyms
- LY3298176, Mounjaro, Zepbound
- Solubility
- Water-soluble (reconstitute with bacteriostatic water)
- Organoleptic profile
- White to off-white lyophilized powder
- Composition
- Synthetic peptide — requires reconstitution
Key attributes
Kit contents
- 1 × Tirzepatide 30mg vial
- Tamper-evident flip-off cap
- Batch-tested for purity (≥99%)
- Lyophilized for stability during shipping
- Bacteriostatic water (3 mL)
Each vial is intended for laboratory use only.
Research usage
How is Tirzepatide 30mg used in research?
Tirzepatide is investigated as a dual-pathway metabolic research peptide, engaging two complementary incretin pathways. In preclinical models it is studied for its capacity to enhance glucose-dependent insulin secretion while modulating appetite and energy balance. Its engineered fatty-diacid moiety and amino-acid substitutions are examined for the extended half-life and once-weekly profile they confer in research systems. Investigators use it to probe incretin-receptor cross-talk, gastric-emptying dynamics, and central appetite-regulating pathways. The 30 mg vial supplies additional material for extended assay panels and higher working concentrations in laboratory settings.
Research reports that dual-pathway incretin co-activation produces greater reductions in glycemia and body weight than single-pathway activation in animal research models. In controlled clinical investigations, doses studied up to 15 mg weekly have been associated with substantial improvements in glycemic markers and reductions in body weight across the SURPASS and SURMOUNT programs. Preclinical studies describe enhanced insulin sensitivity, delayed gastric emptying, and reduced food intake following receptor activation. The 30 mg presentation is intended solely to provide more research material and higher working concentrations; it does not correspond to any characterized dose, and efficacy figures reported in the literature pertain only to the 5–15 mg range studied.
The complete safety and toxicological profile of tirzepatide has not been completely characterized. In the published literature, metabolic research peptides of this class are associated with dose-dependent gastrointestinal effects and injection-site reactions across the ranges studied. This material is for laboratory research use only and is not for human or veterinary use. It should be handled only by qualified personnel using appropriate protective equipment and good laboratory practices.
Recommended ratio
- 3 mL of bacteriostatic water per 30 mg vial
- Equivalent to 10 mg/mL (i.e. 1 mg per 10 units on a 100 U insulin syringe)
- Remove the plastic flip-off lid from the vial.
- Disinfect the rubber stoppers with alcohol wipes.
- Inject the diluent slowly down the inner wall of the vial to avoid foaming.
- Gently swirl the vial (never shake). Let it dissolve for about 10 minutes.
Unopened / before reconstitution
- Store at a stable temperature.
- Stable for 24 months.
- For long-term storage (2+ years), store at -20 °C.
Reconstituted solution
- Must be kept refrigerated.
- Avoid exposure to light and excessive heat.
Research journal
Related articles
Research
6 min read
Metabolic research peptides
Semaglutide, tirzepatide, and Triple R — three metabolic research peptides, each a step further into multi-pathway research.
Read article
Research
7 min read
How gut-derived signalling regulates weight
How the body's gut-derived signalling regulates appetite, body weight, and metabolism, and why analogues like semaglutide and tirzepatide became central to obesity research.
Read article